SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

2/12/24 10:18:54 AM ET

Medical/Dental Instruments

Health Care

Get the next $SYK alert in real time by email

SC 13G/A 1 filingtext2023.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. |17| Stryker Corporation (Name of Issuer) Common Stock, $.10 Par Value (Title of Class of Securities) 863667101 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,see the Notes). -------------------------------------------------------------------------------- CUSIP No. 863667101 13G/A Page 2 of 6 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Greenleaf Trust 38-3416104 ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] Not Applicable (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION State of Michigan ________________________________________________________________________________ 5. SOLE VOTING POWER 136,681 NUMBER OF _________________________________________________________________ SHARES 6. SHARED VOTING POWER BENEFICIALLY OWNED BY EACH 18,586,714 REPORTING _________________________________________________________________ PERSON WITH 7. SOLE DISPOSITIVE POWER 97,306 _________________________________________________________________ 8. SHARED DISPOSITIVE POWER 18,626,089 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 18,723,395 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.9% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON* BK ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! -------------------------------------------------------------------------------- Item 1(a) Name of Issuer: Stryker Corporation Item 1(b) Address of Issuer's Principal Executive Offices: 2825 Airview Boulevard Kalamazoo, MI 49002 Item 2(a) Name of Person Filing: Greeneaf Trust Item 2(b) Address of Principal Business Office or, if None, Residence: 211 South Rose Street Kalamazoo, MI 49007 Item 2(c) Citizenship: State of Michigan Item 2(d) Title of Class of Securities: Common Stock, $.10 Par Value Item 2(e) CUSIP Number: 863667101 -------------------------------------------------------------------------------- Item 3. If this statement is filed pursuant to Rules 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [_] Broker or dealer registered under Section 15 of the Act (15 U.S.C.78o); (b) [X] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C.78c); (c) [_] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C.78c); (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C.8a-8); (e) [ ] An Investment Adviser in accordance with Section 240. 13d-1(b)(1) (ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Section 240. 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Section 240. 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.80a-3); (j) [_] Group, in accordance with Section 240. 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Section 240 13d-1(c), check this box. [ ] Item 4. Ownership. (a) Amount beneficially owned: 18,723,395 (b) Percent of class: 4.9% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 136,681 (ii) Shared power to vote or to direct the vote 18,586,714 (iii) Sole power to dispose or to direct the disposition of 97,306 (iv) Shared power to dispose or to direct the disposition of 18,626,089 -------------------------------------------------------------------------------- Item 5. Ownership of Five Percent or Less of a Class. Not Applicable If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Greenleaf Trust holds these securities in a fiduciary capacity on behalf of various trust and investment management customers, some of whom have the right to receive, or the power to direct the receipt of, dividends from or the proceeds from the sale of these securities Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 9, 2024 (Date) /s/ Michael F. Odar ----------------------------- (Signature) Michael F. Odar, President Greenleaf Trust (Name/Title)

Get the next $SYK alert in real time by email

Date	Price Target	Rating	Analyst
2/26/2025	$450.00	Buy	Citigroup
12/2/2024	$370.00 → $445.00	Equal-Weight → Overweight	Morgan Stanley
9/10/2024	$405.00	Outperform	Wolfe Research
5/30/2024	$372.00	Neutral	Goldman
5/22/2024	$392.00	Hold → Buy	Needham
1/31/2024	$315.00 → $360.00	Hold → Buy	Canaccord Genuity
10/20/2023	$345.00	Buy	ROTH MKM
9/5/2023	$310.00 → $315.00	Neutral → Buy	BofA Securities

SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

Chat with this insight

Recent Analyst Ratings for
$SYK

$SYK
Press Releases

Fastest customizable press release news feed in the world

Stryker receives FDA clearance for Incompass Total Ankle System

Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System

Stryker declares an $0.84 per share quarterly dividend

$SYK
SEC Filings

SEC Form S-8 filed by Stryker Corporation

SEC Form SD filed by Stryker Corporation

Stryker Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

$SYK
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 3 filed by new insider King Debra

Amendment: VP, Chief Accounting Officer Berry William E Jr covered exercise/tax liability with 1,005 shares, decreasing direct ownership by 28% to 2,643 units (SEC Form 4)

Amendment: VP, Chief Accounting Officer Berry William E Jr sold $211,370 worth of shares (755 units at $279.96), decreasing direct ownership by 29% to 1,853 units (SEC Form 4)

$SYK
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Citigroup resumed coverage on Stryker with a new price target

Stryker upgraded by Morgan Stanley with a new price target

Wolfe Research initiated coverage on Stryker with a new price target

SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

Chat with this insight

Recent Analyst Ratings for $SYK

$SYK Press Releases

Fastest customizable press release news feed in the world

Stryker receives FDA clearance for Incompass Total Ankle System

Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System

Stryker declares an $0.84 per share quarterly dividend

$SYK SEC Filings

SEC Form S-8 filed by Stryker Corporation

SEC Form SD filed by Stryker Corporation

Stryker Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

$SYK Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 3 filed by new insider King Debra

Amendment: VP, Chief Accounting Officer Berry William E Jr covered exercise/tax liability with 1,005 shares, decreasing direct ownership by 28% to 2,643 units (SEC Form 4)

Amendment: VP, Chief Accounting Officer Berry William E Jr sold $211,370 worth of shares (755 units at $279.96), decreasing direct ownership by 29% to 1,853 units (SEC Form 4)

$SYK Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Citigroup resumed coverage on Stryker with a new price target

Stryker upgraded by Morgan Stanley with a new price target

Wolfe Research initiated coverage on Stryker with a new price target

Recent Analyst Ratings for
$SYK

$SYK
Press Releases

$SYK
SEC Filings

$SYK
Insider Trading

$SYK
Analyst Ratings